This month, the FDA approved a nasal spray version of the drug epinephrine, a potentially ground-breaking alternative to auto-injectors like EpiPen for people with serious allergies. The nasal spray, ...
neffy is commercially available in the U.S. for the emergency treatment of allergic reactions, including anaphylaxis, in adults and children aged 4 years and older who weigh at least 33 pounds (15 kg) ...
SAN DIEGO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves ...
San Diego, USA-based ARS Pharmaceuticals has announced that China’s National Medical Products Administration (NMPA) has ...
Aug. 26—Those at risk of a severe allergic reaction always have handy an EpiPen just in case. But soon their life might be saved by a spray in the nose rather than a needle to the thigh. Last week the ...
The nasal spray, marked as neffy, is intended as an emergency treatment for severe allergic reactions. Neffy is the first needle-free alternative to shots like EpiPen. The FDA said it approved the ...
The availability of neffy 1 mg extends protection to younger, school-aged children—who make up nearly 23% of people needing epinephrine Visit neffy.com for savings and support programs and pay as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback